Clinical Trial Update: Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing how anticoagulation therapy affects cognitive decline and dementia in patients with non-valvular atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Ischemic Events
• Cognition Disorders
• Dementia
• Non-valvular Atrial Fibrillation

Snippet

Sponsor: Intermountain Health Care, Inc. | Conditions: Dementia, Cognition Disorders | Phase 4 | Status: COMPLETED